Manotti named senior vice president, chief development officer at MSKCC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Kenneth Manotti has been named senior vice president and Chief Development Officer at Memorial Sloan Kettering Cancer Center.

Manotti has more than 30 years of fundraising and leadership experience at major institutions, including the University of Pennsylvania, Columbia University, the American University in Cairo, and the University of Chicago. He was senior vice president of University Development and Alumni Relations at New York University.

Manotti’s appointment concludes a national search for new leadership for MSK’s fundraising program, which was led for the past 15 years by Richard Naum as senior vice president for Development and Anne McSweeney as Special Advisor to the President.

Under their direction, the Campaign for MSK surpassed its $3.5 billion goal, providing vital support for innovation and discovery research to transform cancer treatment in New York and around the globe.

At the University of Chicago, where Manotti served as vice president for Alumni Relations and Development from 2011 to 2017, he helped direct a successful $5 billion capital campaign, working collaboratively with university leadership, trustees, and advancement colleagues.

Before that, he served as vice president for Institutional Advancement at the AUC, where he led university-wide development, alumni affairs, and marketing and communications programs in the United States, the Middle East, and Europe. Prior to his work at the AUC, he was associate dean for External Affairs at the University of Pennsylvania’s Wharton School of Business, where he directed the $550 million Wharton Campaign.

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login